Search results
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled...
Fortune via Yahoo Finance· 2 days agoJørgensen has volunteered to testify to the U.S. Senate to defend the massive markup Americans pay...
Gateway - Quartz
Quartz· 23 hours agoNovo Nordisk’s nearly $1,000 per month diabetes medication Ozempic can be produced for less than $5 a month, according ...
Ozempic, Wegovy Maker Agrees to Tesitfy on Senate Hearing for Overpricing Concerns
iTech Post· 1 day agoOzempic and Wegovy maker Novo Nordisk will finally testify to the Senate amid growing concerns about...
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 7 days agoJames Grant, chief medical officer for the Detroit-based insurer. The elimination by Blue Cross of...
New KFF Analysis Finds Costly GLP-1 Drugs ( includes Wegovy and Ozempic) are Rarely Covered for...
Sierra Sun Times· 6 days agoWegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace prescription drug plans, compared to 82% of Marketplace prescription drug plans for Ozempic< ...
Here's how to stay safe among rising Ozempic-related scams
Consumer Affairs· 6 days agoWith consumers flocking to Ozempic in recent months, it should come as no surprise that related...
Scammers make millions selling nonexistent Ozempic, report finds
Newsweek· 5 days agoWeight-loss drugs are in high demand, and scammers are cashing in on the craze. Phishing attempts...
Sen. Sanders calls for Novo Nordisk subpoena over Wegovy and Ozempic pricing
BenefitsPRO· 7 days agoSen. Bernie Sanders is ramping up his battle over the cost of two popular obesity-fighting drugs in...
Drugmaker to testify on why weight-loss drugs cost 15x more in the US
Ars Technica· 2 days agoAfter some persuasion from Sen. Bernie Sanders (I-Vt.), the CEO of Novo Nordisk will testify before...
Use of weight loss and diabetes drugs like Ozempic has skyrocketed in Mass.
WBUR Boston· 5 days agoThe number of Massachusetts residents prescribed a relatively new class of drugs used for diabetes...